Northern Trust’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,414
Closed -$1.94K 4665
2022
Q4
$1.94K Hold
17,414
﹤0.01% 4642
2022
Q3
$18K Hold
17,414
﹤0.01% 4569
2022
Q2
$32K Hold
17,414
﹤0.01% 4542
2022
Q1
$62K Hold
17,414
﹤0.01% 4488
2021
Q4
$150K Hold
17,414
﹤0.01% 4301
2021
Q3
$132K Sell
17,414
-1,742
-9% -$14.7K ﹤0.01% 4330
2021
Q2
$127K Sell
19,156
-93,473
-83% -$589K ﹤0.01% 4301
2021
Q1
$1.36M Buy
+112,629
New +$2.23M ﹤0.01% 3448

Other funds holding LHDX

Northern Trust's LHDX Position: Q1 2023 in Review

Northern Trust sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 17,414 shares — an estimated $1.94K sold.

Northern Trust first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $1.36M in Q1 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • Northern Trust reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 17,414 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $1.94K.
  • Northern Trust first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Northern Trust's Lucira Health, Inc. Common Stock position peaked at $1.36M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.